ArticleFrontiers in toxicology2026
Next-generation full-thickness human skin models produced using 3D electrospun scaffolds and animal-component-free culture media.
Article in Frontiers in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: In vitro full-thickness human skin (FT-Skin) models are important tools for testing of cosmetics and chemicals, screening of new pharmaceuticals, and human disease modeling research. However, these skin models commonly utilize animal-derived collagen as a main structural element of the stromal matrix. Animal-derived collagen constructs suffer from stability and contraction issues, resulting in short lifespan and poor reproducibility. Additionally, culture media utilized to produce these models commonly contain undesirable animal-derived components including fetal bovine serum (FBS) and bovine pituitary extract (BPE). Methods: To address these shortcomings, FT-Skin models were developed without animal-derived collagen by using electrospun scaffolds as a structural component of the stromal constructs, together with FBS- and BPE-free culture media formulations. Results: These novel culture protocols and media formulations produced well-developed FT-Skin models with improved lifespan and barrier properties. Protocol transferability, and intra- and inter-lot reproducibility of the FT-Skin models were demonstrated by testing in 2 independent laboratories. Discussion: These next-generation FT-Skin models offer opportunities for completely animal-product-free testing of cosmetics and chemicals, screening of new pharmaceuticals and more human-relevant modeling of skin diseases. The electrospun scaffolds and basic processes for development of animal-free subepithelial stromal constructs are also anticipated to be adaptable to the development of additional epithelial tissue models such as ocular, airway and intestine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.